Baseline diabetes as a way to predict CV outcomes in a lipid-modifying trial: a meta-analysis of 330,376 patients from 47 landmark studies

Conclusions: Absolute and relative CV risk associated with diabetes at inclusion can be readily predicted using linear equations relating diabetes prevalence to primary outcomes or CHD rates.

http://www.cardiab.com/content/14/1/60

Source: Cardiovascular Diabetology - May 21, 2015 Category: Cardiology Authors: Michel HermansEvariste BouenizabilaDaniel Amoussou-guenouSylvie AhnMichel Rousseau Source Type: research